tiprankstipranks
Trending News
More News >
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Income Statement

Compare
582 Followers

Mineralys Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Mineralys Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Mineralys Therapeutics, Inc.'s net income was $-36.93M. See Mineralys Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -43.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 192.40M$ 84.66M$ 31.48M$ 18.73M$ 2.94M
Depreciation and Amortization
$ 43.00K$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -192.36M$ -84.66M$ -31.48M$ -19.38M$ -3.31M
Operating Income
$ -192.40M$ -84.66M$ -31.48M$ -18.73M$ -2.94M
Other Income/Expenses
$ 14.59M$ 12.76M$ 1.68M$ -683.00K$ -483.00K
Pretax Income
$ -177.81M$ -71.90M$ -29.80M$ -19.41M$ -3.43M
Net Income
$ -177.81M$ -71.90M$ -29.80M$ -19.41M$ -3.43M
Per Share Metrics
Basic EPS
$ -3.66$ -1.99$ -5.77$ -3.89$ -0.74
Diluted EPS
$ -3.66$ -1.99$ -5.77$ -3.89$ -0.74
Weighted Average Shares Outstanding
48.54M 36.19M 5.17M 4.98M 4.63M
Weighted Average Shares Outstanding (Diluted)
48.54M 36.19M 5.17M 4.98M 4.63M
Currency in USD

Mineralys Therapeutics, Inc. Earnings and Revenue History